Pharming Group N.V.
PHAR
$11.72
-$0.63-5.10%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 06/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 1.64M | -5.21M | 5.33M | 4.69M | 4.69M |
| Total Depreciation and Amortization | 2.85M | 3.12M | 2.31M | 2.70M | 2.70M |
| Total Amortization of Deferred Charges | -- | -- | 893.00K | -- | -- |
| Total Other Non-Cash Items | 3.99M | 3.60M | 2.86M | 5.74M | 9.48M |
| Change in Net Operating Assets | -18.14M | 445.00K | -685.00K | -1.39M | -5.13M |
| Cash from Operations | -9.66M | 1.95M | 10.71M | 11.74M | 11.74M |
| Capital Expenditure | -83.00K | -238.00K | -269.00K | -128.00K | -128.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 0.00 | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -84.52M | 224.00K | 17.08M | 17.08M |
| Cash from Investing | -83.00K | -84.76M | -45.00K | 16.96M | 16.96M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -919.00K | -12.98M | -1.37M | -1.07M | -1.07M |
| Issuance of Common Stock | 1.22M | 3.88M | 5.25M | 1.05M | 1.05M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.75M | -125.00K | -2.84M | -2.74M | -2.74M |
| Cash from Financing | -2.45M | -9.22M | 1.04M | -2.76M | -2.76M |
| Foreign Exchange rate Adjustments | 292.00K | -895.00K | 1.24M | 6.06M | 6.06M |
| Miscellaneous Cash Flow Adjustments | 117.80M | -1.00K | 0.00 | -- | -- |
| Net Change in Cash | 105.90M | -92.93M | 12.94M | 32.00M | 32.00M |